{"nct_id":"NCT01960348","title":"APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis","status":"COMPLETED","status_verified_date":"2018-11","start_date":"2013-11","start_date_type":null,"primary_completion_date":"2017-08","primary_completion_date_type":"ACTUAL","completion_date":"2017-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ALNY"]}